| scholarly article | Q13442814 |
| P356 | DOI | 10.7326/0003-4819-155-7-201110040-00017 |
| P698 | PubMed publication ID | 21969351 |
| P50 | author | Harry R Dalton | Q43056922 |
| Samreen Ijaz | Q73343733 | ||
| P2093 | author name string | Richard Bendall | |
| Joe Mathew | |||
| Frances E Keane | |||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | chronic hepatitis | Q62019625 |
| patient | Q181600 | ||
| hepatitis E | Q326643 | ||
| P304 | page(s) | 479-480 | |
| P577 | publication date | 2011-10-01 | |
| P1433 | published in | Annals of Internal Medicine | Q564416 |
| P1476 | title | Treatment of chronic hepatitis E in a patient with HIV infection | |
| P478 | volume | 155 |
| Q38188419 | An update on hepatitis B, D, and E viruses. |
| Q38073654 | An update on the hepatitis E virus. |
| Q36730005 | Antiviral Activities of Different Interferon Types and Subtypes against Hepatitis E Virus Replication |
| Q38174398 | Antiviral strategies for hepatitis E virus |
| Q40044816 | Brainstem encephalitis and acute polyneuropathy associated with hepatitis E infection. |
| Q26784271 | Chronic hepatitis E: A brief review |
| Q26996422 | Chronic hepatitis e virus infection and treatment |
| Q26777824 | Epidemiology of Hepatitis E Virus in European Countries |
| Q33418110 | Extra-hepatic manifestations of autochthonous hepatitis E infection |
| Q33430954 | Extrahepatic manifestations of hepatitis E virus |
| Q37573028 | Fetal and neonatal health consequences of vertically transmitted hepatitis E virus infection |
| Q40827067 | Full coding hepatitis E virus genotype 3 genome amplification method. |
| Q56656388 | Hepatitis E |
| Q91811401 | Hepatitis E Infection in HIV-Infected Patients |
| Q56915346 | Hepatitis E Virus |
| Q38716400 | Hepatitis E Virus Infects Neurons and Brains. |
| Q28354374 | Hepatitis E Virus in Industrialized Countries: The Silent Threat |
| Q41144722 | Hepatitis E Virus of Subtype 3a in a Pig Farm, South-Eastern France |
| Q38681788 | Hepatitis E virus and neurological injury |
| Q37544935 | Hepatitis E virus infection |
| Q56752720 | Hepatitis E virus infection |
| Q26777044 | Hepatitis E virus infection: Epidemiology and treatment implications |
| Q38379216 | Hepatitis E: A disease of reemerging importance |
| Q93140759 | Hepatitis E: The nonendemic perspective |
| Q64082955 | Hepatitis E: an underestimated emerging threat |
| Q38137898 | Hepatitis E: current status. |
| Q38066540 | Hepatitis E: source and route of infection, clinical manifestations and new developments |
| Q30234939 | Hepatitis E: the current state of play. |
| Q38192527 | Hepatitis e virus: current concepts and future perspectives |
| Q37544940 | Host immune status and response to hepatitis E virus infection. |
| Q36870923 | Identification of Distribution Characteristics and Epidemic Trends of Hepatitis E in Zhejiang Province, China from 2007 to 2012. |
| Q47561286 | Immunity against hepatitis E virus infection: Implications for therapy and vaccine development |
| Q38096721 | Intervention strategies for emerging viruses: use of antivirals |
| Q38699244 | Prophylaxis against hepatitis E: at risk populations and human vaccines. |
| Q41097685 | Ribavirin for Chronic Hepatitis Prevention among Patients with Hematologic Malignancies |
| Q37544484 | Ribavirin inhibits in vitro hepatitis E virus replication through depletion of cellular GTP pools and is moderately synergistic with alpha interferon |
| Q93222302 | Swine hepatitis E virus: cross-species infection, pork safety and chronic infection |
| Q26740390 | Treatment of HEV Infection in Patients with a Solid-Organ Transplant and Chronic Hepatitis |
| Q40507403 | Treatment of Hepatitis E. |
Search more.